儿童癫痫急救医疗服务中基于年龄的咪达唑仑剂量优化(PediDOSE)研究的方法学
PediDOSE是一项在20个城市急救医疗服务系统中实施的阶梯楔形试验,比较基于四个年龄分组的咪达唑仑给药方案与现行基于体重的给药方案在癫痫停止和呼吸衰竭方面的效果与安全性。研究旨在评估年龄分组给药能否在不增加呼吸衰竭的前提下更有效地在到达急诊科前停止癫痫发作。
要点
- 现行急救医疗服务实践导致儿童癫痫患者咪达唑仑给药不足和延迟。
- PediDOSE试验在20个城市急救系统实施基于四个年龄分组的咪达唑仑给药方案。
- 主要目标是比较年龄分组给药与体重给药在到达急诊科时癫痫停止的效果。
核心结论
- 若研究表明基于年龄分组的急救医疗服务给药方案安全且比现行实践更有效,可能带来儿童癫痫治疗的范式转变,并易于在全国急救系统中实施。
- 年龄分组给药的概念也可能适用于其他常见儿科院前情况。
研究设计与样本
- 在儿科急诊护理应用研究网络(PECARN)中开展的大型急救医疗服务系统阶梯楔形试验。
- 在20个城市的急救系统癫痫方案中实施基于四个年龄分组的咪达唑仑给药。
- 主要终点为比较基于年龄分组与基于体重的咪达唑仑给药在到达急诊科时癫痫停止的效果。
- 次要终点为确定实施基于年龄分组的咪达唑仑给药后儿童呼吸衰竭的频率。
主要发现
- 当前急救医疗服务实践导致抗癫痫药物给药不足和延迟。
- 一项院前循证指南推荐使用鼻内或肌内咪达唑仑作为儿童癫痫的一线治疗。
- 尽管尝试实施这些指南,三分之一由急救人员目击癫痫发作的儿童在到达急诊科时仍有持续癫痫发作,这可能归因于咪达唑仑给药不足或延迟。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seizures are one of the most common reasons for emergency medical services (EMS) activation for children, and current EMS practice results in underdosing and delayed delivery of anti-seizure medication. A prehospital evidence-based guideline recommends using intranasal or intramuscular midazolam as first-line treatment for pediatric seizures. Despite attempts to implement these guidelines, one-third of children having a paramedic-witnessed seizure have ongoing seizures on emergency department (ED) arrival; this may be due to inadequate or delayed midazolam dosing. Replacing the error-prone, sequential calculations with age-based midazolam dosing may be simpler, faster, and more effective without compromising safety. The objective of this manuscript is to describe the methodology of the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) study, a clinical trial designed to compare the effectiveness and safety of an EMS protocol with four age-based categories for midazolam dosing relative to the current weight-based dosing. METHODS: We are conducting a large EMS-based stepped wedge trial in the Pediatric Emergency Care Applied Research Network (PECARN) by implementing midazolam dosing based on four age categories in seizure protocols in EMS systems in 20 cities. We believe that this implementation will stop more seizures before ED arrival without increasing respiratory failure rates. The primary aim of this study is to compare the effectiveness of age-based EMS midazolam dosing compared to the current weight-based dosing on seizure cessation upon ED arrival. The secondary aim is to determine the frequency of respiratory failure in children after the implementation of EMS midazolam dosing based on these age categories. CONCLUSION: If this study demonstrates that an EMS patient care protocol with age-based midazolam dosing is safe and more effective than current practice, the potential impact of this study is a paradigm shift in the treatment of pediatric seizures that can be easily implemented in EMS systems across the country. Beyond seizures, the concept of age-based dosing may also be applicable to other commonly encountered pediatric prehospital conditions for which medication may be indicated.
引用
- Shah MI, Adelgais KM, Chamberlain JM, et al. Methodology for the Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study. Trials. 2025. PMID: 41388551. doi:10.1186/s13063-025-09342-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。